Behind the science

Getting ahead of infectious diseases

The predictive power of genetics, genomics, and AI holds the key to transforming medical discovery for the better

Read article
Respiratory syncytial virus
Close Video

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
Go to infectious diseases
HIV
38m
people are living with HIV worldwide
Go to HIV
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Go to oncology
Immunology
25yrs
of leading research to help people with inflammatory conditions
Go to immunology
Behind the science

Discover how we're getting ahead

Harnessing tumour DNA to detect cancer recurrence earlier

Scientist in lab

Antibiotic resistance: now’s the time to prevent the next pandemic

Red blood cells

Using new science to get ahead of myelofibrosis - a rare blood cancer

Getting ahead of COPD exacerbations using new tech could save lives

GSK scientist works in a laboratory in the UK

The logic of biologic medicines: advancing care for people with immune-mediated conditions

Eosinophils cell

Eosinophils could be holding the missing link between symptoms, diagnosis and treatment

Man talking in a meeting

Time for a change: personalising asthma treatment

R&D scientist walking through chemistry smart lab.

Unlocking the power of the immune system to get ahead of hepatitis B

Quality team meeting

Tackling tomorrow’s health challenges today

GSK quality lab operator engaged in focussed task.

How vaccine science can help tackle antimicrobial resistance

Read our magazine

Life at GSK

How we help people thrive 

Studio portrait - light background - 8

Culture

At GSK, culture is something we all own. It’s powered by the little things GSK people do every day to help us get ahead of disease together. It drives delivery of our strategy and makes GSK a place people can thrive. Being ambitious for patients, accountable for impact and making sure we always do the right thing is how we deliver for patients, shareholders, and of course the people who work here.

The Code     Purpose, strategy and culture

Man smiling

Growth

Helping people grow professionally and personally is fundamental to GSK. Because we know when individuals grow, our company grows too. Everyone at GSK is encouraged to drive their development through a blend of on-the-job experiences, plus best-in-class formal and informal learning.

Life at GSK

Man smiling

Diversity, equity and inclusion

We’re dedicated to diversity, equity and inclusion in what we do and how we do it. Because it's the right thing to do and it helps us perform better. That’s why we focus on recognising and making the most of our differences and encourage everyone to bring their authentic selves to work. We make sure everyone gets equal opportunities and we’re fully committed to ensuring our workforce reflects the communities in which we work.

Diversity, equity and inclusion

Scientists conversing over skeletal formulae

Wellbeing

We prioritise personal wellbeing so that our people can thrive both in and out of work. We achieve this by fostering a healthy and safe working space for them to succeed and grow. Above all, working at GSK means working with colleagues, friends and managers who support, motivate and care for one another every step of the way.

Life at GSK

Careers at GSK
icon

Outstanding people

Mugdha 1280
INNOVATING TOGETHER 2022
Meet Mugdha: working together to help more patients
GSK Precisionpoint 1280X720 Trust Tim (1)
WORKING TOGETHER
Meet Tim: valuing neurodiversity in Global Health
GSK Precisionpoint 1280X720 Trust Fiona
WORKING TOGETHER
Meet Fiona: improving health and wellbeing through nature
GSK Precisionpoint 1280X720 Trust Andy
WORKING TOGETHER
Meet Andy: how a life-changing diagnosis changed his career
GSK Twist Small 1280X720 Employee Alison
MY GSK STORY
Meet Alison: taking pride in working for GSK
Pal 1280
INNOVATING TOGETHER 2022
Meet Pal: combining the power of genetics and genomics
View all series

Positively impacting society and the planet

Baby laughing

Pricing and access

We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.

Scientist inspecting a vial

Global health and health security

We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally.

Scientist in laboratory

Diversity, equity and inclusion

Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.

Young girl leaving front door

Environmental sustainability

We are working towards a net zero impact on climate and a net positive impact on nature by 2030, across our full value chain.

Scientist in conversation

Product governance

Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.

Group of scientists in the lab

Ethical standards

Our culture guides our people to do the right thing and act on any concerns they have.

In the spotlight

MEDIA

GSK announces new global headquarters in central London

MEDIA

GSK tops Access to Medicine Index (ATMI) for eighth consecutive time​

INVESTORS

GSK delivers strong Q3 2022 sales of £7.8 billion +18% AER, +9% CER and Total EPS 255.9p +>100% AER, +>100% CER; Adjusted EPS of 46.9p +25% AER, +11% CER

INVESTORS

We announced our third quarter 2022 results on Wednesday 2 November.

View latest results

Continue to Company

Back to top